<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02545348</url>
  </required_header>
  <id_info>
    <org_study_id>StLucGsendo1</org_study_id>
    <nct_id>NCT02545348</nct_id>
  </id_info>
  <brief_title>Use of the Sentinel Node Biopsy for Early Endometrial Cancer.</brief_title>
  <acronym>SNE</acronym>
  <official_title>Evaluation (Good Medical Practice Evaluation) of the Use of the Sentinel Node Biopsy in Early Stage Endometrial Cancer and Its Implication on the Adjuvant Treatement and on the Outcomes of the Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an obstervationnal study, to evaluate the good clinical practice of the use of the
      sentinel node biospy in early stage endometrial cancer. The collaborating centres with the
      OncoGynecology board of the King Albert II Institute of the Clinique Universitaire Saint-Luc
      will also particpate to the trial.

      Sentinel node biospy is not yet validated for endometrial cancer, even if lots of leading
      team in the world published very good result and that the first prospectives trials are
      already published with also excellents results. The investigators decided then to include
      this practice in their institutional guideslines and also to registred the procedure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All the sentinel node biopsy procedures for endometrial cancer will be record online via the
      REDCap tools, securized on a servor in Saint-Luc. Automatic email for the following of the
      patients and the post operative event will be send regularly for every patient to the
      physicians who include the patient. Efficacy of the technique, False negative and postive
      rate, modifications of the adjuvant treatement, long terme evolution and complication wil be
      evaluate.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Anticipated">September 2020</completion_date>
  <primary_completion_date type="Anticipated">January 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Detection rate of the sentinel lymph node biopsy regarding diffrent methods used by the investigators</measure>
    <time_frame>5 years</time_frame>
    <description>Each hemi pelvis is count as an unit for the detection rate, but also the detection per patient will be calculated. For a positive detection with the patient as an unit, the detection must be bilateral</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Modification of the adjuvant treatement by the information bring by the sentinel node analysis</measure>
    <time_frame>5 years</time_frame>
    <description>An evaluation of the modification of the adjuvant treatement by the results of the node sentinel will be performed, in case of it was performed alone and then compared to the guides lines when no information on the nodal status is knowed. It will also be evaluated in cas where a complete lymphadenectomy was performed to evaluate the interest of the ultrastaging on the sentinel node.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Survival outcomes: Disease free survival (DFS) and Overvall survival (OS) will be evaluate.</measure>
    <time_frame>5 years</time_frame>
    <description>Influence of the use of the sentinel node only or in addition to the complete lymphadenectomy on the DFS and the OS by comparing with the litterature accorded DFS and OS will be evaluate. Type of reccurence will also be attentively observed, in order to ensure the safety of the sentinel node dissection only. If the technique is reliable, the rate of nodal reccurence after negative sentinel node should be low.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>False positive rate of the frozen section analysis</measure>
    <time_frame>5 years</time_frame>
    <description>Each negative sentinel node at the frozen section analyse wil also undergo a second analysis after &quot;calssical&quot; preparation of the tissue and alos immunochemestry analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>False negative rate of the sentinel node, after frosen section analyse and the complete analysis</measure>
    <time_frame>5 years</time_frame>
    <description>In the group of patient who underwent a complet lymphadenectomy, a false negative rate will be calculate, with a expected number really low.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Early and late complications of the procedure</measure>
    <time_frame>5 years</time_frame>
    <description>Per operative, early and late post operative complication related to the sentinel node procedure will be recorded in the REDCap file, and will be compared to the group of complete lymphadenectomy, with a special focus on lymphatics complications (lymphocyst, lymphoedema,...)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Cancer of Endometrium</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sentinel Lymph Node Biopsy</intervention_name>
    <description>First, the detection of the sentinel node will be preformed at the beginning of the surgery. Differents detection methods are use and the efficacy of each will be recorded. Second, dissection and extraction of the sentinel node will be performed, to send it to the frozen section examination. Third, other lymph node could be removed if the surgeon evaluate that it is feasible and necessary. In this group, the false negative rate will be also evaluate.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All the patient with early stage endometrial cancer, whith or without indication of
        complete lymphadenectomy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Endometrial cancer early stage on the pre operative examinations

          -  Performance status that allow a surgery

          -  Surgery by laparoscopy or laparotomy

        Exclusion Criteria:

          -  Patient already operated of the hysterectomy who need lymphatic restadification

          -  Stage IV disease
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luyckc Luyckx</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cliniques universitaires Saint-Luc</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mathieu LUYCKX</last_name>
    <phone>27649509</phone>
    <phone_ext>+32</phone_ext>
    <email>mathieu.luyckx@uclouvain.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jean-Luc Squifflet</last_name>
    <phone>27649501</phone>
    <phone_ext>+32</phone_ext>
    <email>jean-luc.squifflet@uclouvain.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU AMbroise Parée</name>
      <address>
        <city>Mons</city>
        <state>Hainaut</state>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kurt Crener, MD</last_name>
      <email>Kurt.Crener@hap.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cliniques de l'Europe</name>
      <address>
        <city>Brussel</city>
        <zip>1180</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Waterkeyn</last_name>
      <email>marcwaterkeyn@yahoo.fr</email>
    </contact>
    <contact_backup>
      <last_name>Alain Charles</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Cliniques universitaires Saint-Luc</name>
      <address>
        <city>Brussel</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mathieu Luyckx</last_name>
      <phone>27646009</phone>
      <phone_ext>+32</phone_ext>
      <email>mathieu.luyckx@uclouvain.be</email>
    </contact>
    <contact_backup>
      <last_name>Jean-Luc Squifflet</last_name>
      <phone>27641071</phone>
      <phone_ext>+32</phone_ext>
      <email>jean-luc.squifflet@uclouvain.be</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Clinique St Jean</name>
      <address>
        <city>Brussel</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Paul Van gossum, MD</last_name>
      <email>jpvangossum@clstjean.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital d'Ixelles</name>
      <address>
        <city>Brussel</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frédéric BUXANT, MD</last_name>
      <email>FBUXANT@his-izz.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cliniques Saint-Anne - Saint Remi</name>
      <address>
        <city>Bruxelles</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bruno Vandermeersch, MD</last_name>
      <email>bruno.vandermeersch@skynet.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>GHDC</name>
      <address>
        <city>Charleroi</city>
        <zip>6000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gregory Vanvinckeroy</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Université de Liège</name>
      <address>
        <city>Liège</city>
        <zip>6000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frédéric Kridelka, PhD</last_name>
      <phone>04/367.95.19</phone>
      <email>frederic.kridelka@chu.ulg.ac.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cliniques Saint-Pierre Ottignies</name>
      <address>
        <city>Ottignies</city>
        <zip>1340</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vincent Malvaux</last_name>
      <email>Vincent.MALVAUX@cspo.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHWaPi</name>
      <address>
        <city>Tournai</city>
        <zip>7500</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mathieu Jouret</last_name>
      <email>Mathieu.JOURET@chwapi.be</email>
    </contact>
    <contact_backup>
      <last_name>Marc Wayemberg</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 3, 2015</study_first_submitted>
  <study_first_submitted_qc>September 7, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 9, 2015</study_first_posted>
  <last_update_submitted>May 3, 2018</last_update_submitted>
  <last_update_submitted_qc>May 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</investigator_affiliation>
    <investigator_full_name>Luyckx</investigator_full_name>
    <investigator_title>Assistant Chief Resident - Gynecologic Oncology - King Albert Institute</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endometrial Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

